Safety trials for treatment of the faulty C9orf72 gene are due to start in the last quarter of this year both in the USA and UK. However, I learned at the John Radcliffe yesterday that these trials are likely to be delayed well into next year for bureaucratic reasons. Treatment will be an intrathecal injection into the spine, so that the drug gets into the cerebro-spinal fluid that bathes the brain. The trial is likely to be double blind, so one could get a placebo injected. A single shot would last 6 months or more. The people at the John Radcliffe have no control over who is selected to take part in the trial. The point of the trial, as the title suggests, is to provide assurance that the treatment is indeed a safe one. They told me that they are pretty sure that it will be safe. From my point of view, I place little hope that this treatment will arrive in time to help me. I might not be selected for the trial and if I was, I might be given the plac...